Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Scandion Oncology A/S announces its results for the third quarter of 2021

Scandion Oncology today announces its third quarter report for 2021. The following is taken from the report. Bo Rode Hansen, President and CEO comments “During the third quarter, Scandion Oncology has continued the transformation towards the Cancer Drug Resistance company according to the company’s strategy. We completed the first Capital Markets Day where we conveyed the strategy for the registrational path to market of our clinical programs.” Key figures & highlights TDKK Q3 2021 Q3 2020 Q1-Q3 2021 Q1-Q3 2020 2020 Net sales

Nomination Committee RugVista Group AB (publ) appointed

The Nomination Committee of RugVista Group AB (publ) (“RugVista”) has been formed in accordance with the company’s “Instruction for appointing the Nomination Committee” as adopted by the Annual General Meeting. The Nomination Committee appointed for RugVista’s 2022 Annual General Meeting has the following composition: · Andreas Nyberg (representative of Litorina IV L.P) · Klara Tersman (representative of TIN Fonder) · Erik Lindgren (chairperson of the RugVista Board and the Nomination Committee) Shareholders who wish to submit proposals to the Nomination Committee are welcome

Talkpool Interim Report, January - September 2021

[][][][] Jul 1[st] – Sep 30[th], 2021 Jan 1[st] – Sep 30[th], 2021 · Net sales amounted to EUR 5 831 · Net sales amounted to EUR 17 768thousand (5 112), a 14.1 percent thousand (14 883), a 19.4 percentincrease increase · EBITDA of EUR 352 thousand (282) · EBITDA of EUR 783 thousand (486)and EBITDA margin of 6.0 percent (5.5) and EBITDA margin of 4.4 percent (3.3) · EBIT of EUR 285 thousand (172) · EBIT of EUR 523 thousand (183)and EBIT margin of 4.9 percent (3.4) and EBIT margin of 2.9 percent (1.

KEBNI RELEASES QUARTERLY REPORT FOR Q3 2021, JULY - SEPTEMBER

KebNi tightens the arc.During the third quarter of the year, KebNi took its starting point in the future. In parallel with deliveries to our customer in Israel and thus a stabilized cash flow, as well as further focus on sales work with more customer visits and quotation deliveries, intensive strategy work has been done during the quarter. Within that work, we have seen great opportunities and have paved the way to reach them. KebNi plans to grow both organically and through acquisitions. The organic part of the business plan states that KebNi aims to:• Grow SATCOM faster than the

Formica Capital invests 115 MSEK in ChargeNode

ChargeNode, a green tech company that eliminates the need for traditional EV chargers, has raised 115 MSEK from Formica Capital to accelerate Swedish and international expansion. ChargeNode fits very well into Formica’s focus on fast-growing companies with climate-effective solutions for properties, being Formica’s fifth investment in this segment. ChargeNode’s patent-pending technology for EV charging consists of a central charging unit that enables charging of more than 50 electric vehicles. Its innovative charging technology reduces power requirement and operational cost while

KONE completes repurchase of own shares

KONE Corporation, stock exchange release, November 18, 2021 at 9.20 a.m. EET KONE completes repurchase of own shares KONE has completed the repurchase of the company’s own class B shares, which started on November 11, 2021 and ended on November 17, 2021. During this period, a total of 750,000 own shares were repurchased for an average price of EUR 60.9629 per share. The shares were repurchased in public trading on Nasdaq Helsinki Ltd. at the market price prevailing at the time of purchase. The shares were repurchased on the basis of the authorization given by the Annual General

BioStock: PolarCool enters English Premier League market

PolarCool’s brain cooling device for treating concussions, PolarCap System, continues to make to breakthroughs in new markets. This week, the Swedish medtech company has announced signing an agreement with the English Premier League club Leeds United, thus entering what is arguably the most recognised sports league in the world.Read the article at biostock.se : https://www.biostock.se/en/2021/11/polarcool-enters-english-premier-league-market/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se 

Publication of Anora’s Interim Report for January-September 2021 on 25 November and invitation to results presentation

Anora Group Plc  Press release  18 November 2021 at 9:15 am EET Publication of Anora’s Interim Report for January-September 2021 on 25 November and invitation to results presentation Anora will publish its Interim Report for January–September 2021 on Thursday 25 November at around 8:30 am EET. CEO Pekka Tennilä and CFO Sigmund Toth will present the report on the same day at 11:00 am EET. The presentation will be held as a Microsoft Teams Meeting. We recommend that participants join the event using the online meeting option: Join meeting here 

Quarterly report July - September Everysport Media Group AB (publ)

"The third quarter is characterized by growth, strategic acquisitions and important key recruitments", says Hannes Andersson, CEO Everysport Media Group AB. Summary of the third quarter 2021 · Net sales*: 43,3 mkr (20,0 mkr) · EBITDA: 6,6 mkr (2,1 mkr) · EBIT: −3,1 mkr (1,2 mkr) · Profit after tax: −3,1 mkr (0,5 mkr) · Earnings per share: −0,19 kr (0,10 kr) · Cashflow from operating activities: 3,5 mkr (−3,2 mkr)* including acquired sales through Trav og Galoppnyt SEK 6,3 million and Every Padel SEK 14 million Summary January - September 2021 · Net sales*:

Arctic Bioscience Q3 2021 Operational Update

· Psoriasis phase IIb study for HRO350 on track: site feasibility process ongoing in Europe as planned with positive response from sites with access to patients for H1 2022. · New GMP manufacturing facility in Ørsta: Building process commenced, with planned finalization H2 2023. In-house manufacturing of our nutraceutical and investigational pharmaceutical products is expected to significantly improve company-wide gross margins. · Full year adjusted EBITDA forecast in expected range of NOK -25 to -30 million · Year-end cash position remains very solid, forecast in the range of NOK

Anora publishes historical pro forma financial information

Anora Group Plc   Stock Exchange Release  18 November 2021 at 9:00 am EET Anora publishes historical pro forma financial information Anora publishes historical pro forma financial information for the full year of 2020 and 2019, and for the first six months of 2021. The attached pro forma information has been prepared to illustrate the effects of the merger of Altia and Arcus and to facilitate the comparability of Anora’s financial information. The pro forma information is unaudited and it includes also quarterly data. Historical pro forma information is presented for illustrative

CS MEDICA A/S: Publication of Year-end report

CS MEDICA A/S (”CS MEDICA” or the ”Company”) hereby publishes its year-end report for the period October 2020 –September 2021. The report is available as an attached document to this press release and on the Company’s website (www.cs-medica.com). Below is a summary of the report.Performance highlights   · Operating profit for the year increased by 165% in Danish kroner and in the fourth quarter with 1.130% compared to 2019/2020.  · Net Sales for the year increased by 51% in Danish kroner compared to 2019/2020. Net Sales in the fourth quarter increased by 682% in Danish kroner

Q3 Report – 30 September 2021

Flexion sees its best-ever quarter in terms of game signings and continues to grow its quarterly revenue by 26% and gross profit by 27% year on year.July 2021 to September 2021 performance · Total revenue increased by 26% to GBP 7.8m (GBP 6.2m)* · Gross profit increased by 27% to GBP 1.0m (GBP 0.8m) · Adjusted EBITDA[‡] remained flat at GBP 0.07m (GBP 0.11m) · Operating result remained flat at GBP -0.02m (GBP 0.05m) · Earnings per share amounted to GBP -0.07 pence (GBP 0.08 pence) · Cash amounted to GBP 15.1m (GBP 3.7m) April 2021 to September 2021 performance ·

Consortium led by Aker Offshore Wind secures blade recycling pilot project funding

A UK Government grant has been secured for an innovative pilot to develop the UK’s first wind blade turbine recycling plant.The £2million three-year project involves a consortium led by Aker Offshore Wind and Scottish researchers, with the aim of ensuring a more sustainable future for the global wind industry and the wider composites manufacturing industry – accelerating the drive towards net zero emissions and waste and creating new skills and job opportunities in the UK. The pilot will now get underway to develop a commercially viable solution, overseen by industry lead Aker Offshore

Coor receives payment from collectively bargained AGS group sickness insurance policy

Afa Försäkring has decided to make lump-sum payments of surpluses within the collectively bargained AGS group sickness insurance policy. For Coor Service Management Holding AB this is expected to have a positive impact on EBIT in the fourth quarter of 2021 of approx. SEK 40 M.In June 2021, Afa Sjukförsäkringsaktiebolag’s board of directors resolved on a payment to certain employers within the collectively bargained AGS group sickness insurance policy. Underpinning the decision is a favorable trend on the stock market and previous changes to the group sickness insurance system in 2008, which

Dignitana AB Publishes Q3 2021 Interim Report

Moving toward cash flow positivity in 2022 with accelerating reimbursement activityFinancial highlights Q3 2021 · Net sales amounted to 13,7 MSEK (10.9),  an increase of 25 percent over the same period 2020. · Operating result amounted to -13.6 MSEK (-9,5) · Net result after financial items amounted to -13.9 MSEK (-9.9) · Earnings per share were -0,21 SEK (-0,18) · Cash Balance amounted to 21.0 MSEK (14.8) · Average Daily Treatment Revenue (ADTR)* was 147 TSEK (99), an increase of 47 percent over the same period in 2020. Financial highlights January – September 2021

Notice of Extraordinary General Meeting of Aspire Global Plc

18[th] November 2021 Notice of Extraordinary General Meeting of Aspire Global Plc The shareholders of Aspire Global Plc (the “Company”) are hereby invited to an extraordinary general meeting of the Company, which will be held on Thursday 9[th] December 2021 remotely via Microsoft Teams, in terms of the Companies Act (Public Companies – Annual General Meetings) Regulations and the Company’s Articles of Association. The meeting will start at 2.00pm CET. Right to participate Shareholders who wish to participate at the extraordinary general meeting must: · be entered in the

Operations update

EnQuest PLC, 18 November 2021 Operations update EnQuest Chief Executive, Amjad Bseisu, said: "We are delighted to have completed the acquisition of the Golden Eagle area. As a highly cash generative, low-cost asset, delivering material incremental production, reserves and resources, Golden Eagle is a great addition to our portfolio, further strengthening the Company. "Revenue and cash flow continues to be positively impacted by the prevailing strong price environment and we expect this to continue through the end of the year.  "Group production has been challenging, largely

UpCloud appoints Steve Midgley as Chair of the Board

[Helsinki, 18.11.2021] UpCloud, the European leader in high-performance cloud infrastructure services, announces their new Chair of the Board, Steve Midgley.UpCloud's new Board Chair, Steve Midgley, brings a wealth of knowledge regarding the cloud infrastructure industry. After the €18 million investment that UpCloud secured at the beginning of 2020, Midgley's appointment is another part of the company's transformation towards becoming a partner of scaling and growing online businesses. "Our goal was to bring a strong industry leader who has built and scaled companies in the past in our

Gold&Green Foods and Unicef Finland – building a better future together

Cooperation with UNICEF is one way for Gold&Green Foods to contribute to building a healthier tomorrow for people and the planet. The three-year partnership continues and will be seen in Pulled Oats[®] Tomato products this winter. The cooperation supports UNICEF’s work for the most vulnerable children and increases awareness of the significance of nutrition in the development of children and adolescents, and educates people about the environmental impacts of our food-related choices. There are still many children around the world severely affected by poverty, discrimination and

MPC Container Ships ASA reports Q3 and nine-month 2021 results

· Significantly improved operating revenues of USD 118.5 million and EBITDA of USD 73.6 million, up by 72% and 131%, respectively, compared to Q2 2021. · Continued chartering activity combined with strategic vessel sales in Q3 2021 bring the EBITDA backlog to more than USD 840 million. · The FY 2021 EBITDA guidance increased to USD 305-315 million. Oslo, 18 November 2021 Q3 and nine-month 2021 results: MPC Container Ships ASA ("MPCC" or the "Company", together with its subsidiaries the "Group") today published its unaudited financial report for the nine-month period ended 30

Several steps closer to production as Eurobattery Minerals publishes its Interim Report January – September 2021

Stockholm, 18th of November 2021 – With a new drilling campaign in its Spanish Corcel project, mineral resource calculations and drilling under way in its Finnish Hautalampi project, as well as investigations of several battery mineral opportunities in Germany, Eurobattery Minerals has during the third quarter taken several important steps in delivering on its business strategy to provide the automotive industry with sustainable battery minerals mined exclusively in Europe. The target for the company is to produce and deliver battery minerals by 2023. Third quarter 2021 (corresponding

Interim Report January – September 2021

Significant events during the third quarter 2021 · A cooperation agreement was signed with ABB. · A short-term loan facility amounting to SEK 10.5 million was extended to the year end. · The board decided upon a set off issue of shares against short term loans Third quarter, 1 July – 30 September 2021 · Income amounted to SEK 0 million (0) · Earnings after tax amounted to SEK – 1.9 million (–2.4) · Investments in the period July - September totalled SEK 0.7 million (1.5) · Basic earnings per share were SEK –0.06 (–0.08) Interim period, 1 January – 30 September

Modus Therapeutics publishes interim report for the third quarter 2021

STOCKHOLM, SWEDEN - 18 November 2021: Modus Therapeutics Holding AB (”Modus Therapeutics”) hereby publishes an interim report for the third quarter 2021. The interim report is available as an attached document and on the company's website (www.modustx.com). Below is a summary of the interim report.The third quarter in figures · The loss after tax amounted to TSEK 4 441 (697). · The loss per share amounted to SEK 0,30 (0,12) · The cash flow from current operations was negative in the amount of TSEK 4 226 (942) The first nine-months in figures · The loss after tax amounted

There are no items matching the current filter
There are no more items matching the current filter
Back to top